Market Overview

Dr. Reddy's Announces Saumen Chakraborty as New CFO


Dr. Reddy's Laboratories (NYSE: RDY) today announced that Umang
Vohra, who was the CFO of the company for the past four years, will take
over the role of Executive Vice-President and Head of North America
Generics Business from January 2013.

Subsequently, Saumen Chakraborty has been appointed as the CFO of the
company effective 2 January, 2013. Saumen is currently the President and
Global Head of Quality, HR and IT & Business Process Excellence (BPE) at
Dr. Reddy's. He was also the CFO of Dr. Reddy's between 2006 and 2008.


This press release includes forward-looking statements, as defined in
the U.S. Private Securities Litigation Reform Act

See full press release

Posted-In: News Guidance Contracts Management Global


Related Articles (RDY)

View Comments and Join the Discussion!